Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

GANX

Gain Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · GANX

All alert types
1.13 USD -0.06 -5.04%
As of Oct 30, 2026 Extended hours 1.16 +2.45%
Bid
1.13 × 2
Ask
1.14 × 2
1.11 Day range 1.20
1.13 52-week range 4.18
YTD
-64.91%
1 year
-35.80%
Open
1.18
Prev close
1.19
Mkt cap
49.32M
Vol
364.65K
Avg vol
501.79K
EPS
-0.50
P/E
0.00
Div yield
0.00%
More statistics
Low
1.11
High
1.20
Forward P/E
-1.76
Beta
0.34
Short ratio
1.65
Inst. own
7.96%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
2.05
200-d avg
2.12
1y target
7.33

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GANX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-6.10 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -5.3×
FY 2018: -58.9×FY 2019: -30.3×FY 2020: -37.3×FY 2021: -4.0×FY 2022: -2.1×FY 2023: -1.9×FY 2024: -2.4×FY 2025: -5.3×
FY 2018 5y median -2.4× FY 2025
P/S 0.0×
FY 2018: 3185×FY 2019: 2271×FY 2020: 4606×FY 2021: 335×FY 2022: 265×FY 2023: 771×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 265× FY 2025
P/B 5.7×
FY 2018: -69.0×FY 2019: -208×FY 2020: 21.4×FY 2021: 1.6×FY 2022: 2.0×FY 2023: 3.4×FY 2024: 6.7×FY 2025: 5.7×
FY 2018 5y median 3.4× FY 2025
P/FCF -5.7×
FY 2018: -87.2×FY 2019: -49.8×FY 2020: -40.8×FY 2021: -4.4×FY 2022: -2.5×FY 2023: -2.3×FY 2024: -2.6×FY 2025: -5.7×
FY 2018 5y median -2.6× FY 2025
EV/EBITDA -4.5×
FY 2018: -64.8×FY 2019: -44.7×FY 2020: -36.5×FY 2021: -1.4×FY 2022: -1.8×FY 2023: -1.4×FY 2024: -2.0×FY 2025: -4.5×
FY 2018 5y median -1.8× FY 2025
EV/Sales 0.0×
FY 2018: 3229×FY 2019: 2268×FY 2020: 4390×FY 2021: 121×FY 2022: 222×FY 2023: 576×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 121× FY 2025
FCF Yield -17.4%
FY 2018: -1.1%FY 2019: -2.0%FY 2020: -2.5%FY 2021: -22.6%FY 2022: -39.8%FY 2023: -44.4%FY 2024: -38.2%FY 2025: -17.4%
FY 2018 5y median -38.2% FY 2025

Profitability

Gross Margin 0.0%
FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 100.0% FY 2025
Operating Margin 0.0%
FY 2018: -4989.7%FY 2019: -5084.9%FY 2020: -12047.5%FY 2021: -8379.8%FY 2022: -12688.1%FY 2023: -40328.3%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median -8379.8% FY 2025
Net Margin 0.0%
FY 2018: -5364.4%FY 2019: -5310.9%FY 2020: -12387.7%FY 2021: -8418.9%FY 2022: -12555.1%FY 2023: -40354.3%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median -8418.9% FY 2025
ROE -108.6%
FY 2018: 116.3%FY 2019: 487.6%FY 2020: -57.7%FY 2021: -39.9%FY 2022: -93.2%FY 2023: -177.0%FY 2024: -278.1%FY 2025: -108.6%
FY 2018 5y median -108.6% FY 2025
ROIC -95.0%
FY 2018: -271.7%FY 2019: 1800.2%FY 2020: -45.6%FY 2021: -37.6%FY 2022: -87.5%FY 2023: -158.9%FY 2024: -239.9%FY 2025: -95.0%
FY 2018 5y median -95.0% FY 2025
ROA -88.4%
FY 2018: -136.2%FY 2019: -332.2%FY 2020: -37.3%FY 2021: -35.6%FY 2022: -73.0%FY 2023: -119.7%FY 2024: -168.4%FY 2025: -88.4%
FY 2018 5y median -88.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 100.4%FY 2020: -30.1%FY 2021: 471.3%FY 2022: -15.1%FY 2023: -60.6%FY 2024: -100.0%FY 2025: 0.0%
FY 2018 FY 2025
Operating Income 8.1%
FY 2018: 0.0%FY 2019: -104.2%FY 2020: -65.7%FY 2021: -297.4%FY 2022: -28.6%FY 2023: -25.2%FY 2024: 8.5%FY 2025: 8.1%
FY 2018 FY 2025
EPS (diluted) 31.5%
FY 2018: 0.0%FY 2019: -36.8%FY 2020: -15.4%FY 2021: -356.7%FY 2022: -8.0%FY 2023: -15.5%FY 2024: 48.0%FY 2025: 31.5%
FY 2018 FY 2025
Free Cash Flow 2.3%
FY 2018: 0.0%FY 2019: -150.1%FY 2020: -73.3%FY 2021: -282.1%FY 2022: -18.9%FY 2023: -27.5%FY 2024: -0.1%FY 2025: 2.3%
FY 2018 FY 2025

Financial Health

Current Ratio 6.6×
FY 2018: 0.9×FY 2019: 0.5×FY 2020: 4.2×FY 2021: 14.8×FY 2022: 5.1×FY 2023: 3.6×FY 2024: 3.0×FY 2025: 6.6×
FY 2018 5y median 5.1× FY 2025
Quick Ratio 6.6×
FY 2018: 0.9×FY 2019: 0.5×FY 2020: 4.2×FY 2021: 14.8×FY 2022: 5.1×FY 2023: 3.6×FY 2024: 3.0×FY 2025: 6.6×
FY 2018 5y median 5.1× FY 2025
Debt / Equity 0.0×
FY 2018: -1.4×FY 2019: -0.4×FY 2020: 0.2×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 1.0×
FY 2018: -0.9×FY 2019: 0.0×FY 2020: 1.8×FY 2021: 2.5×FY 2022: 0.3×FY 2023: 0.5×FY 2024: 0.5×FY 2025: 1.0×
FY 2018 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2018: -19.6×FY 2019: -102×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31